Reply to the letter to the editor ‘ESMO-MCBS v1.1: statistical and patient relevant shortcomings’ by Emprechtinger et al
Autor: | J. Tabernero, Christoph C. Zielinski, Georgios Pentheroudakis, Urania Dafni, Nathan I. Cherny, E.G.E. de Vries, J.-Y. Douillard, Dimitris Karlis, Nicola Jane Latino, Panagiota Zygoura, Martine Piccart, Jan Bogaerts |
---|---|
Přispěvatelé: | Guided Treatment in Optimal Selected Cancer Patients (GUTS) |
Rok vydání: | 2018 |
Předmět: |
Letter to the editor
business.industry CONSORT 2010 STATEMENT CLINICAL BENEFIT UPDATED GUIDELINES Hematology computer.software_genre ABSENCE Confidence interval CONFIDENCE-INTERVALS 03 medical and health sciences MAGNITUDE 0302 clinical medicine Oncology 030220 oncology & carcinogenesis GROUP RANDOMIZED-TRIALS Medicine 030212 general & internal medicine Artificial intelligence business computer Natural language processing |
Zdroj: | Annals of Oncology, 29(5), 1335-1338. Oxford University Press |
ISSN: | 0923-7534 |
DOI: | 10.1093/annonc/mdy108 |
Databáze: | OpenAIRE |
Externí odkaz: |